UTHR
What one share of United Therapeutics holds
Pharmaceutical Preparations
Founded by our Chairperson and Chief Executive Officer, Martine Rothblatt, to find a cure for her daughter’s life-threatening rare disease, pulmonary arterial hypertension (PAH), United Therapeutics advances therapies for people living with serious diseases with unmet medical needs.
United Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $67.26 |
|---|---|
| Profit | $27.95 |
| Capex (buildings and equipment) | $12.63 |
| Free cash flow | $23.30 |
| Cash and investments | $89.12 |
| Book value | $149.97 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $34.16 | $15.25 | $0.81 | $12.94 | — | $43.09 |
| 2017 | $38.43 | $9.31 | $1.92 | $8.64 | — | $48.61 |
| 2018 | $37.00 | $13.39 | $4.19 | $13.50 | — | $63.98 |
| 2019 | $33.08 | −$2.39 | $1.91 | −$6.63 | — | $63.36 |
| 2020 | $33.26 | $11.54 | $1.33 | $15.61 | — | $76.28 |
| 2021 | $35.63 | $10.06 | $2.55 | $10.09 | — | $87.77 |
| 2022 | $39.92 | $15.00 | $2.86 | $13.68 | — | $104.20 |
| 2023 | $46.83 | $19.81 | $4.64 | $15.04 | — | $127.23 |
| 2024 | $59.33 | $24.64 | $5.08 | $22.28 | — | $143.74 |
| 2025 | $66.44 | $27.86 | $10.87 | $21.73 | — | $162.60 |